Simbec Company Profile

09:29 EDT 20th March 2018 | BioPortfolio


News Articles [2 Associated News Articles listed on BioPortfolio]

Conducting Early Phase Oncology Studies - Successfully Moving Through to Proof of Concept

TORONTO, ON--(Marketwired - November 27, 2017) - In an upcoming webinar hosted by Xtalks on Tuesday, December 5, 2017, guest speakers from Simbec-Orion Group and Orion Clinical Oncology Advisory Board...

Effective Implementation of the Revised EMA First-into-Human (FIH) Guidance to Accelerate Your Early Clinical Development, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - December 14, 2017) - In this webinar speakers from Simbec Research will discuss the use of integrated protocols (umbrella protocols) to maximise programme efficiency. Att...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study of SENS 401 in Healthy Subjects

Sensorion are the study sponsor and the objective of this study is to investigate the safety and pharmacokinetic (PK) profile of SENS 401 in humans after a single and repeat dose administr...

A Single Dose PK Study of SENS-218 in Healthy Volunteers

This study is to aid the development for the use of SENS-218 outside its marketed therapeutic indications. SENS-218 is available in Asia and is marketed as an anti-emetic (Anti-sickness) d...

More Information about "Simbec" on BioPortfolio

We have published hundreds of Simbec news stories on BioPortfolio along with dozens of Simbec Clinical Trials and PubMed Articles about Simbec for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Simbec Companies in our database. You can also find out about relevant Simbec Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record